Arrow Begins Non-Pulsatile VAD Trial, Targets Mid-Year LionHeart CE Mark
This article was originally published in The Gray Sheet
Executive Summary
Arrow International will commence a 15-patient pilot trial of its centrifugal flow ventricular assist device in Europe by the end of February, the firm announced during its annual stockholders meeting Jan. 15